Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser....

42
Treating the Turkish Patient: Treating the Turkish Patient: Is he different? Is he different? Prof. Prof. Mehdi Mehdi Zoghi Zoghi - - E E ge ge University, University, İ İ zmir zmir Prevention in Prevention in Coronary Artery Coronary Artery Disease Disease 2011 2011

Transcript of Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser....

Page 1: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Treating the Turkish Patient: Treating the Turkish Patient: Is he different?Is he different?

Prof. Prof. MehdiMehdi ZoghiZoghi--EEgege University, University, İİzmirzmir

Prevention in Prevention in Coronary ArteryCoronary Artery DiseaseDisease

20112011

Page 2: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

καλωσόρισμαWELCOME

Page 3: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

5224

19

14

5

0 10 20 30 40 50 60

KVH

Kanser

İnfeksiyonlar

Akc hast.

AIDSHIV

Pulmonary disease

Infections

Cancer

CVD

The World Health Report 2004

Cardiovascular disease (CVD) is a major cause of death

throughout the world.

Page 4: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Percentage of the population citing health as their main

concern before other

issues, such as financial problems,

housing or crime.

Health is among the top personal concerns

!

Primary

health care : Now

more than ever

The world health report 2008

Page 5: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

NHLBI. www.nhlbi.nih.gov

$54

$56

$133

$239

$368$368

$29

0 50 100 150 200 250 300 350 400

Billions of dollars

Congestive heart failure

Stroke

Hypertension

Coronary heart disease

Heart disease

Total CVD†

CVD=Cardiovascular disease

1 of every 3 deaths

Page 6: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Coronary Artery Disease Coronary Artery Disease (CAD) in Turkey(CAD) in Turkey

New CAD: 300.000/year

CAD Mortality: 170.000/year

STEMI: 80.000/year

Turkish

Adult

Risk factor

StudyA. Onat Atherosclerosis

Risk Factors

2001;156,1-10

Page 7: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

45,2

8,5

0

10

20

30

40

50

1999

Over 60 yOver 80 y

Dea

th p

er 1

00,0

00 p

opul

atio

n

Think about where you're going to be in

20502050

Page 8: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

45,2

8,5

97

30

0102030405060708090

100

1999 2050 (estimate)

Over 60 y

Over 80 y

Dea

th p

er 1

00,0

00 p

opul

atio

n

20502050

Page 9: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

• The underling pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms

occur, generally in middle age.

Page 10: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

The major risk factors for CVD are well established, with the principal three modifiable factors being hypertension, dyslipidemia and smoking.

Page 11: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Primary prevention can help prevent 80%

of coronary heart disease.

Page 12: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.
Page 13: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Two complementary strategies that are usually advocated for primary prevention:

The population strategy

aims to reduce the burden of disease in the whole community while conferring small benefits to each individual.

The high-risk strategy, provides large benefits to the few individuals who are most vulnerable but the benefits to the whole community may be relatively limited because the beneficiaries are few.

Page 14: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Risk prediction charts enable the estimation of total cardiovascular risk of

people in the first category.

Total cardiovascular risk means the likelihood of a person developing an atherosclerotic cardiovascular event over a

defined period of time.

Page 15: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Both community-based primary prevention and secondary prevention are needed for

effective CVD prevention and control

Page 16: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

ON

TARGET

55 yrs

Cigarette smoking, Family history (+)

BP: 135/80 mmHg,

TC: 280 mg/dl, LDL-C: 130 mg/dl, HDL-C:35 mg/dl,

Blood glucose: 90 mg/dl, microalbuminuria (-)

ECG: Normal

Echocardiography: Normal

Page 17: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

ON

TARGET

http://hp2010.nhlbihin.net/atpiii/calculator.asp?usertype=prof

10-year risk for developing CHD

Page 18: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

ON

TARGET

Individual counseling and provision of care may have to be prioritized according to cardiovascular risk.

Risk <10% Individuals in this category are at low risk. Conservative management focusing on lifestyle interventions is

suggested.

Risk

10% to <20%Individuals in this category are at moderate risk

of fatal or non-fatal vascular events.Monitor risk profile every 6–12 months.

Risk

>20%Individuals in this category are at high risk of

fatal or non-fatal vascular events.Monitor risk profile every 3–6 months.

Page 19: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

PRESENTATION  NAMECompany name

Risk factor screening

Adults should know the levels and  significance of risk factors as routinely 

assessed by their primary care provider.

Page 20: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Turkish Patient: Is he different?Turkish Patient: Is he different?

Prevention in Prevention in Coronary ArteryCoronary Artery DiseaseDisease

20112011

Page 21: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

The EUROASPIRE III survey was conducted in 2006-2007 in 22

countries in Europe to describe risk factors, lifestyle and

therapeutic management of patients with coronary heart

disease (CHD), compliance with current guidelines, and to

document changes over time.

EUROASPIRE : European

Action

on Secondary and

Primary

Prevention

by

Intervention

to

Reduce

Events

Page 22: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

EUROASPIRE : European

Action

on Secondary and

Primary

Prevention

by

Intervention

to

Reduce

Events

Eur

J Cardiovasc

Prev

Rehabil. 2009 Apr;16(2):121-37

1.

Belgium2.

Bulgaria

3.

Croatia4.

Cyprus

5.

Czech

Republic6.

Finland

7.

France8.

Germany

9.

Greece10.Hungary11.Ireland12.Italy13.Latvia14.Lithuania15.The

Netherlands

16.Poland17.Romania18.Russian

Federation

19.Slovenia20.Spain21.21.TurkeyTurkey22.United

Kingdom

Page 23: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Compared to the EUROASPIRE III data, classical

risk factors did not exhibit

remarkable differences.

Records

from Turkish

centers:1.

Belgium

2.

Bulgaria3.

Croatia

4.

Cyprus5.

Czech

Republic

6.

Finland7.

France

8.

Germany9.

Greece

10.Hungary11.Ireland12.Italy13.Latvia14.Lithuania15.The

Netherlands

16.Poland17.Romania18.Russian

Federation

19.Slovenia20.Spain21.21.TurkeyTurkey22.United

Kingdom Tokgözoğlu

L et al. Turk

Kardiyol

Dern

Ars.

2010;38(3):164-72

Page 24: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

The most important differences were observed in the higher rates of the following:

Young patients with myocardial infarction (<50 years, 20% vs. 12.7%),

Persistence in smoking (23.1% vs. 17.2%), •

İmmobility,

Low HDL-cholesterol •

Insufficient follow-up by physicians after the index event (12% vs. 2.2%),

and •

Insufficient patient education.

EUROASPIRE III survey-Turkish

Data

Tokgözoğlu

L et al. Turk

Kardiyol

Dern

Ars.

2010;38(3):164-72

Page 25: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Risk FactorEurope

(n=8966)Turkey(n=338)

Obesity 35,3 35,5

High BP 56.0 55.2

High Cholesterol 51.1 48.3

Low HDL 36.7 50.2

Diabetes 34.8 33.6

HDL was low in half of pts

Tokgözoğlu

L et al. Turk

Kardiyol

Dern

Ars.

2010;38(3):164-72

Page 26: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

1.

Romania2.

South Cyprus

3.

Turkey....

HDLFemale:46.0 vs

49.5 mgr/dl

Male: 39.4 vs

43.3 mgr/dl

Tokgözoğlu

L et al. Turk

Kardiyol

Dern

Ars.

2010;38(3):164-72

Page 27: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

HDL in Turkish

Population2

Reasons

for Low

Page 28: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

International Physical Activity Questionnaire

Physical ActivityEurope

(n=8966)Turkey(n=338)

Low 54.4 23.1High 39.4 10.5

Page 29: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.
Page 30: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

PREvention and CONtrol Program for Cardiovascular

Diseases in TuRkish POpuLation (PRE-CONTROL)

1) The level and distribution of cardiovascular risk factors in our population,

2) The knowledge and awareness of participants about CVD

3) The evaluation of the effectiveness of prevention education program on awareness of CVD in urban population of Turkey

EUROPREVENT 2011

Page 31: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

A 24-item questionnaire form

was used for detecting cardiovascular risk factors and the awareness of participants about CVD which was concerning personal and family history of disease, education levels, lifestyle factors and heart attack or stroke medications.

The Joint British

Societies’

cardiovascular disease risk prediction chart

was used

for

investigating cardiovascular risk levels (low risk < 10%; intermediate risk 10-20%; high risk > 20%) of participants.

Education programs feed-back data

were collected by questionnaires and individual interviews of participants after 2 weeks of education seminars by telephone surveys.

Page 32: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Total cardiovascular risk

76,4

23,60

1020304050607080

Risk Score %

Moderate-High Low

ÖMER Kozan, MEHDİ

Zoghi, GÜLAY Güven

Sain, M Arıcı, ÜLVER Derici, GÖKSEL Bakaç, SEVİM Güllü, OKTAY Ergene

on behalf of PRE-CONTROL study investigators, Presented in EUROPREVENT 2011

Page 33: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

PRE-CONTROL

PRE-CONTROL

Although the cardiovascular risk is high (moderate or high risk rate was 74.6%) the knowledge and

awareness of the risk factors for cardiovascular disease are low in our community.

Only 21% of participants with cardiovascular risk score more than 10%

have visited any physician within last year.

Page 34: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

PRE-CONTROL

PRE-CONTROL

Community-based educational programs are helpful to increase public

awareness, health promotion and management of

cardiovascular

diseases.

The awareness of cardiovascular diseases and risk factors was significantly increased following our

education programs.

ÖMER Kozan, MEHDİ

Zoghi, GÜLAY Güven

Sain, M Arıcı, ÜLVER Derici, GÖKSEL Bakaç, SEVİM Güllü, OKTAY Ergene

on behalf of PRE-CONTROL study investigators, Presented in EUROPREVENT 2011

Page 35: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Risk Factor

Sex: Male Male

Age (yrs): 36 50Smoker: - -Diabetes: - -Blood Pressure: 130/80 130/80 Total Cholestrol 200 200

HDL Cholesterol: 36 36

5%

10%

You can’t change everything

Page 36: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Brigitte Bardot

Page 37: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Marlon BrandoMarlon Brando

Page 38: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Gregory PeckGregory Peck

Page 39: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

MadonnaMadonna

Page 40: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

AjdaAjda PekkanPekkan (Famous Turkish Pop Singer(Famous Turkish Pop Singer))

Page 41: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

DemisDemis RoussosRoussos

Page 42: Treating the Turkish Patient: Is he different?€¦ · 52 24 19 14 5. 0 102030405060 KVH Kanser. İ. nfeksiyonlar Akc hast. AIDS. HIV. Pulmonary disease. Infections. Cancer. CVD.

Σας

ευχαριστώ

για

την προσοχή

σας